Lv511
1016 积分 2023-05-16 加入
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
12天前
已完结
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
12天前
已完结
distinct inflammasome IL-1β gene expression profile in patients with psoriatic arthritis in Basra city
17天前
已完结
P1114 Engineering and Development of a Novel Bispecific Antibody Targeting IL-23 and TL1A
29天前
已关闭
Discovery and Phase 1 study of a novel monoclonal antibody against human IL-1β for the treatment of IL-1β-mediated diseases
1个月前
已完结
Designing and Evaluation of a Novel IL-1RA Fusion Cytokine to Enhancethe Pharmacokinetics and Receptor Affinity for Better TherapeuticIntervention in Inflammatory Disorders
1个月前
已完结
Molecular mechanisms of regulation of IL-1 and its receptors
1个月前
已完结
SAT0447 Safety, Tolerability and Pharmacokinetics of Abt-981, an IL-1A and IL-1β Dual Target Biologic Drug in Development for Osteoarthritis, following Single Dose Administration in Healthy Subjects
1个月前
已完结
The role of interleukin-1 beta in inflammation and the potential of immune-targeted therapies
1个月前
已完结
IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis
1个月前
已完结
皖公网安备34019202002308
